BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8326135)

  • 1. Improved renal function in mouse kidney allografts lacking MHC class I antigens.
    Coffman T; Geier S; Ibrahim S; Griffiths R; Spurney R; Smithies O; Koller B; Sanfilippo F
    J Immunol; 1993 Jul; 151(1):425-35. PubMed ID: 8326135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of chronic renal allograft injury by injection of a monoclonal antibody against a donor MHC Ib molecule in a nude rat model.
    Koch M; Broecker V; Heratizadeh A; Doege C; Strehlau J; Mengel M; Nashan B
    Transpl Immunol; 2008 Jul; 19(3-4):187-91. PubMed ID: 18595711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine orthotopic corneal transplantation in high-risk eyes. Rejection is dictated primarily by weak rather than strong alloantigens.
    Sano Y; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 1997 May; 38(6):1130-8. PubMed ID: 9152232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indirect T cell allorecognition and alloantibody-mediated rejection of MHC class I-disparate heart grafts.
    Pettigrew GJ; Lovegrove E; Bradley JA; Maclean J; Bolton EM
    J Immunol; 1998 Aug; 161(3):1292-8. PubMed ID: 9686590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo immunosuppressive effect and the decreasing expression of MHC class II antigens by purine nucleoside phosphorylase inhibitor 8-amino-9-benzylguanine in recipient tissues of canine renal allograft rejection.
    Yen CY; Lin CY
    J Surg Res; 1996 May; 62(2):260-6. PubMed ID: 8632649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel tool for B-cell tolerance research: characterization of mouse alloantibody development using a simple and reliable cellular ELISA technique.
    Fan X; Tyerman K; Ang A; Koo K; Parameswaran K; Tao K; Mai L; Lang H; West LJ
    Transplant Proc; 2005; 37(1):29-31. PubMed ID: 15808536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective breeding of miniature swine leads to an increased rate of acceptance of MHC-identical, but not of class I-disparate, renal allografts.
    Rosengard BR; Ojikutu CA; Fishbein J; Kortz EO; Sachs DH
    J Immunol; 1992 Aug; 149(3):1099-103. PubMed ID: 1634765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of donor MHC antigen expression ameliorates chronic kidney allograft rejection.
    Mannon RB; Griffiths R; Ruiz P; Platt JL; Coffman TM
    Kidney Int; 2002 Jul; 62(1):290-300. PubMed ID: 12081591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How T cells recognize alloantigen: evidence for two pathways of allorecognition.
    Watschinger B
    Nephrol Dial Transplant; 1995; 10(9):1556-8. PubMed ID: 8559468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Abeta(b-/-), H2-DM(-), and CIITA(-/-) in second-set skin allograft rejection.
    Felix NJ; de Serres S; Meyer AA; Ting JP
    J Surg Res; 2002 Feb; 102(2):185-92. PubMed ID: 11796017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of MHC class I-related Chain B (MICB) molecules on renal transplant biopsies.
    Quiroga I; Salio M; Koo DD; Cerundolo L; Shepherd D; Cerundolo V; Fuggle SV
    Transplantation; 2006 Apr; 81(8):1196-203. PubMed ID: 16641608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germ-line transmission of a disrupted beta 2-microglobulin gene produced by homologous recombination in embryonic stem cells.
    Zijlstra M; Li E; Sajjadi F; Subramani S; Jaenisch R
    Nature; 1989 Nov; 342(6248):435-8. PubMed ID: 2685607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An immunodominant minor histocompatibility alloantigen that initiates corneal allograft rejection.
    Haskova Z; Sproule TJ; Roopenian DC; Ksander AB
    Transplantation; 2003 Apr; 75(8):1368-74. PubMed ID: 12717232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered intragraft immune responses and improved renal function in MHC class II-deficient mouse kidney allografts.
    Mannon RB; Doyle C; Griffiths R; Bustos M; Platt JL; Coffman TM
    Transplantation; 2000 May; 69(10):2137-43. PubMed ID: 10852613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement contributes to the rejection of complete and class I major histocompatibility complex--incompatible cardiac allografts.
    Qian Z; Jakobs FM; Pfaff-Amesse T; Sanfilippo F; Baldwin WM
    J Heart Lung Transplant; 1998 May; 17(5):470-8. PubMed ID: 9628565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
    Nickel P; Bold G; Presber F; Biti D; Babel N; Kreutzer S; Pratschke J; Schönemann C; Kern F; Volk HD; Reinke P
    Transpl Immunol; 2009 Mar; 20(4):238-42. PubMed ID: 19032982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rejection of kidney allografts by MHC class I-deficient mice.
    Mannon RB; Nataraj C; Kotzin BL; Griffiths R; Geier S; Ibrahim S; Sanfilippo FP; Platt JL; Kurlander R; Coffman TM
    Transplantation; 1995 Mar; 59(5):746-55. PubMed ID: 7886804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emerging issue of MICA antibodies: antibodies to MICA and other antigens of endothelial cells.
    Stastny P; Zou Y; Fan Y; Qin Z; Lavingia B
    Contrib Nephrol; 2009; 162():99-106. PubMed ID: 19001817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xenografts of MHC-deficient mouse embryonic mesencephalon improve behavioral recovery in hemiparkinsonian rats.
    Veng LM; Bjugstad KB; Freed CR; Marrack P; Clarkson ED; Bell KP; Hutt C; Zawada WM
    Cell Transplant; 2002; 11(1):5-16. PubMed ID: 12095220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.